SCHEMBL1891289

SCHEMBL1891289

CCCCCCCCCCCCCCCCCC(=O)N1CCO1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.57
L3MBTL1 Q9Y468 2/20 0.55
TDP1 Q9NUW8 3/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
GNAI3 P08754 4/20 0.51
GNAI1 P63096 4/20 0.51
GNAO1 P09471 3/20 0.49
FAAH O00519 1/20 0.49
CES2 O00748 3/20 0.46
CES1 P23141 3/20 0.46
PPARG P37231 5/20 0.45
PPARD Q03181 5/20 0.45
PPARA Q07869 5/20 0.45
HDAC11 Q96DB2 4/20 0.45
TSHR P16473 3/20 0.45
GPR84 Q9NQS5 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TLR2 O60603 2/20 0.45
FABP4 P15090 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11804449 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL11807471 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL11801606 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL4555686 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL11807679 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL11799918 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL4556690 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL4556296 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL11804402 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A
SCHEMBL11805317 1.00 NAAA (0.57) NAAAL3MBTL1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117460531-A Pharmaceutical formulations containing anti-IgE antibodies 诺华股份有限公司 2024-01-26 CN disclosed
US-8772400-B2 Polyvinyl alcohol-based film for optical use, polarizing film, and polarizing plate THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) 2014-07-08 US disclosed
US-8577256-B2 Electrostatic image developing carrier, electrostatic image developer, process cartridge, image forming method, and image forming apparatus FUJI XEROX CO., LTD. (JP) 2013-11-05 US disclosed
US-8530412-B2 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device CANON KABUSHIKI KAISHA (JP) 2013-09-10 US disclosed
US-20130017482-A1 ELECTROSTATIC IMAGE DEVELOPING CARRIER, ELECTROSTATIC IMAGE DEVELOPER, PROCESS CARTRIDGE, IMAGE FORMING METHOD, AND IMAGE FORMING APPARATUS FUJI XEROX CO., LTD. (JP) 2013-01-17 US disclosed
US-20110104113-A1 EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE CANON KABUSHIKI KAISHA (JP) 2011-05-05 US disclosed
US-20090316264-A1 POLYVINYL ALCOHOL-BASED FILM FOR OPTICAL USE, POLARIZING FILM, AND POLARIZING PLATE THE NIPPON SYNTHETIC CHEMICAL INDUSTRY CO., LTD. (JP) 2009-12-24 US disclosed
US-20090060869-A1 EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE CANON KABUSHIKI KAISHA (JP) 2009-03-05 US disclosed
EP-1865934-A1 EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE Canon Kabushiki Kaisha (JP) 2007-12-19 EP disclosed
US-7208592-B2 Process for alkali saponification of cellulose ester film surface FUJIFILM CORPORATION (JP) 2007-04-24 US disclosed
WO-2006107009-A1 EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE CANON KABUSHIKI KAISHA (JP) 2006-10-12 WO disclosed
US-20030194668-A1 Process for alkali saponification of polymer film FUJI PHOTO FILM CO., LTD. 2003-10-16 US disclosed
US-3932224-A Method of preventing scale from being deposited in case of producing fresh water from sea water KEISHIN MATSUMOTO DIRECTOR-GENERAL OF THE AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JA) 1976-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090060869-A1 EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE FABP3, CETP, EBPL NAAA 1197/4885L3MBTL1 2145/4885TDP1 4102/4885
US-20110104113-A1 EJECTION LIQUID, EJECTION METHOD, METHOD OF MAKING DROPLETS FROM LIQUID, CARTRIDGE AND EJECTION DEVICE FABP3, CETP, EBPL NAAA 1197/4885L3MBTL1 2145/4885TDP1 4102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.